SCHEMBL4905784

SCHEMBL4905784

CCN(c1ccc2ccccc2c1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
ESR1 P03372 2/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TSHR P16473 1/20 0.46
MCL1 Q07820 3/20 0.46
BCL2L1 Q07817 2/20 0.46
HTR1A P08908 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
HTR7 P34969 1/20 0.46
DRD3 P35462 1/20 0.46
HTR6 P50406 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 2/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903799 0.88 LMNA (0.59) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4902665 0.87 ENPP2 (0.50) LMNAALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL4903818 0.86 ESR1 (0.52) LMNAESR1ALDH1A1MCL1BCL2L1
SCHEMBL4902733 0.84 ESR1 (0.60) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4897517 0.83 ALDH1A1 (0.49) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4896026 0.83 ALDH1A1 (0.49) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4908245 0.83 TP53 (0.46) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4898279 0.83 MAPT (0.51) LMNAESR1ALDH1A1TSHRSMN1; SMN2
SCHEMBL4905129 0.83 MMP13 (0.52) LMNAESR1ALDH1A1TSHRSMN1; SMN2
SCHEMBL4906761 0.82 ALDH1A1 (0.48) LMNAESR1ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885ESR1 473/4885ALDH1A1 2664/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ESR1 585/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.